annual CFF:
$180.13M+$12.33M(+7.35%)Summary
- As of today (July 6, 2025), PRCT annual cash flow from financing activities is $180.13 million, with the most recent change of +$12.33 million (+7.35%) on December 31, 2024.
- During the last 3 years, PRCT annual CFF has fallen by -$81.99 million (-31.28%).
- PRCT annual CFF is now -31.28% below its all-time high of $262.12 million, reached on December 31, 2021.
Performance
PRCT Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$1.30M-$169.23M(-99.24%)Summary
- As of today (July 6, 2025), PRCT quarterly cash flow from financing activities is $1.30 million, with the most recent change of -$169.23 million (-99.24%) on March 1, 2025.
- Over the past year, PRCT quarterly CFF has dropped by -$1.29 million (-49.81%).
- PRCT quarterly CFF is now -99.25% below its all-time high of $174.12 million, reached on September 30, 2021.
Performance
PRCT quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$178.84M-$1.29M(-0.72%)Summary
- As of today (July 6, 2025), PRCT TTM cash flow from financing activities is $178.84 million, with the most recent change of -$1.29 million (-0.72%) on March 1, 2025.
- Over the past year, PRCT TTM CFF has increased by +$8.84 million (+5.20%).
- PRCT TTM CFF is now -31.79% below its all-time high of $262.18 million, reached on March 31, 2022.
Performance
PRCT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PRCT Cash from financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +7.3% | -49.8% | +5.2% |
3 y3 years | -31.3% | +0.5% | -31.8% |
5 y5 years | +579.0% | - | - |
PRCT Cash from financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -31.3% | +4886.9% | -99.2% | +198.5% | -0.7% | +7781.8% |
5 y | 5-year | -31.3% | +4886.9% | -99.3% | +198.5% | -31.8% | >+9999.0% |
alltime | all time | -31.3% | +4886.9% | -99.3% | +198.5% | -31.8% | >+9999.0% |
PRCT Cash from financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $1.30M(-99.2%) | $178.84M(-0.7%) |
Dec 2024 | $180.13M(+7.3%) | $170.53M(+9843.3%) | $180.13M(+1345.3%) |
Sep 2024 | - | $1.72M(-67.6%) | $12.46M(-92.8%) |
Jun 2024 | - | $5.30M(+104.8%) | $172.87M(+1.7%) |
Mar 2024 | - | $2.59M(-9.8%) | $170.00M(+1.3%) |
Dec 2023 | $167.79M(+4545.5%) | $2.87M(-98.2%) | $167.79M(+2.6%) |
Sep 2023 | - | $162.12M(+6571.6%) | $163.61M(+7110.7%) |
Jun 2023 | - | $2.43M(+539.5%) | $2.27M(-16.0%) |
Mar 2023 | - | $380.00K(-128.8%) | $2.70M(-25.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2022 | $3.61M(-98.6%) | -$1.32M(-269.6%) | $3.61M(-35.2%) |
Sep 2022 | - | $777.00K(-72.9%) | $5.57M(-96.9%) |
Jun 2022 | - | $2.86M(+121.7%) | $178.92M(-31.8%) |
Mar 2022 | - | $1.29M(+100.5%) | $262.18M(+0.0%) |
Dec 2021 | $262.12M(+145.5%) | $644.00K(-99.6%) | $262.12M(+0.2%) |
Sep 2021 | - | $174.12M(+102.2%) | $261.47M(+199.3%) |
Jun 2021 | - | $86.13M(+6930.6%) | $87.35M(+7030.6%) |
Mar 2021 | - | $1.23M | $1.23M |
Dec 2020 | $106.77M(+302.5%) | - | - |
Dec 2019 | $26.53M | - | - |
FAQ
- What is PROCEPT BioRobotics annual cash flow from financing activities?
- What is the all time high annual CFF for PROCEPT BioRobotics?
- What is PROCEPT BioRobotics annual CFF year-on-year change?
- What is PROCEPT BioRobotics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for PROCEPT BioRobotics?
- What is PROCEPT BioRobotics quarterly CFF year-on-year change?
- What is PROCEPT BioRobotics TTM cash flow from financing activities?
- What is the all time high TTM CFF for PROCEPT BioRobotics?
- What is PROCEPT BioRobotics TTM CFF year-on-year change?
What is PROCEPT BioRobotics annual cash flow from financing activities?
The current annual CFF of PRCT is $180.13M
What is the all time high annual CFF for PROCEPT BioRobotics?
PROCEPT BioRobotics all-time high annual cash flow from financing activities is $262.12M
What is PROCEPT BioRobotics annual CFF year-on-year change?
Over the past year, PRCT annual cash flow from financing activities has changed by +$12.33M (+7.35%)
What is PROCEPT BioRobotics quarterly cash flow from financing activities?
The current quarterly CFF of PRCT is $1.30M
What is the all time high quarterly CFF for PROCEPT BioRobotics?
PROCEPT BioRobotics all-time high quarterly cash flow from financing activities is $174.12M
What is PROCEPT BioRobotics quarterly CFF year-on-year change?
Over the past year, PRCT quarterly cash flow from financing activities has changed by -$1.29M (-49.81%)
What is PROCEPT BioRobotics TTM cash flow from financing activities?
The current TTM CFF of PRCT is $178.84M
What is the all time high TTM CFF for PROCEPT BioRobotics?
PROCEPT BioRobotics all-time high TTM cash flow from financing activities is $262.18M
What is PROCEPT BioRobotics TTM CFF year-on-year change?
Over the past year, PRCT TTM cash flow from financing activities has changed by +$8.84M (+5.20%)